Details of the Metabolic Reaction (MR)
General Information of This Metabolic Reaction (MR) (ID: MR006696) | ||||||
---|---|---|---|---|---|---|
Formula |
CYP3A4
...
Aliphatic hydroxylation
|
|||||
Reactant | Dronabinol | Product | 11-OH-delata-Tetrahydrocannabinol | |||
Reactant Info | Product Info | |||||
Metabolic Enzyme | Cytochrome P450 3A4 (CYP3A4) | DME Info | ||||
Mephenytoin 4-hydroxylase (CYP2C19) | DME Info | |||||
Cytochrome P450 2C9 (CYP2C9) | DME Info | |||||
Metabolic Type | Oxidation - Aliphatic hydroxylation | |||||
Other MR(s) Related to The Product of This MR | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other MR(s) That Produce The Product of This MR | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
Other MR(s) That Metabolize The Produtc of This MR | |||||||||||||||||||||||||||||
|
References | ||||||
---|---|---|---|---|---|---|
1 | Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. | |||||
2 | CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin. Biochem Pharmacol. 2005 Oct 1;70(7):1096-103. | |||||
3 | Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids | |||||
4 | Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions | |||||
5 | Cytochromes P450: a structure-based summary of biotransformations using representative substrates Drug Metab Rev. 2008;40(1):1-100. doi: 10.1080/03602530802309742. | |||||
6 | Techniques and technologies for the bioanalysis of Sativex?, metabolites and related compounds |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.